Cell Reports (Jul 2024)

Hypoxia drives HIF2-dependent reversible macrophage cell cycle entry

  • Bo Meng,
  • Na Zhao,
  • Petra Mlcochova,
  • Isabella A.T.M. Ferreira,
  • Brian M. Ortmann,
  • Tanja Davis,
  • Niek Wit,
  • Jan Rehwinkel,
  • Simon Cook,
  • Patrick H. Maxwell,
  • James A. Nathan,
  • Ravindra K. Gupta

Journal volume & issue
Vol. 43, no. 7
p. 114471

Abstract

Read online

Summary: Low-oxygen conditions (hypoxia) have been associated primarily with cell-cycle arrest in dividing cells. Macrophages are typically quiescent in G0 but can proliferate in response to tissue signals. Here we show that hypoxia (1% oxygen tension) results in reversible entry into the cell cycle in macrophages. Cell cycle progression is largely limited to G0-G1/S phase transition with little progression to G2/M. This cell cycle transitioning is triggered by an HIF2α-directed transcriptional program. The response is accompanied by increased expression of cell-cycle-associated proteins, including CDK1, which is known to phosphorylate SAMHD1 at T592 and thereby regulate antiviral activity. Prolyl hydroxylase (PHD) inhibitors are able to recapitulate HIF2α-dependent cell cycle entry in macrophages. Finally, tumor-associated macrophages (TAMs) in lung cancers exhibit transcriptomic profiles representing responses to low oxygen and cell cycle progression at the single-cell level. These findings have implications for inflammation and tumor progression/metastasis where low-oxygen environments are common.

Keywords